Gang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gang Liu has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Guangju Guan
Nephrology Research Institute of Shandong University, The Second Hospital of Shandong University, Shandong University, Jinan, Shandong, China
7 shared publications Li-Na Sun
Nephrology Research Institute of Shandong University, The Second Hospital of Shandong University, Shandong University, Jinan, Shandong, China
4 shared publicationsAili Sun
Department of Endocrinology, The Second Hospital of Shandong University, Ji'nan, Shandong Province, China
3 shared publicationsJing Cheng
Nephrology Research Institute of Shandong University, The Second Hospital of Shandong University, Ji'nan, Shandong Province, China
3 shared publicationsShasha Lv
Nephrology Research Institute of Shandong University, The Second Hospital of Shandong University, Ji'nan, Shandong Province, China
3 shared publicationsWeiwei Wang
Nephrology Research Institute of Shandong University, The Second Hospital of Shandong University, Ji'nan, Shandong Province, China
3 shared publications
Latest Publications
- Open Access
- 3 March 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Splice-switching of the oncogenic BCS1L isoform suppresses ovarian cancer progression by disrupting mitochondrial function
Increasing evidences demonstrate that mitochondrial function is essential for cancer cell survival and metastasis. However, the role of mitochondrial metabolic reprogramming in ovarian cancer progression remains largely unknown. Here, we report that mitochondrial chaperone BCS1L generates two major alternative-spliced isoforms, a full-length isoform ( BCS1L-L ) and a short isoform lacking exon 2 ( BCS1L-S ). Interestingly, BCS1L-L is elevated in several human cancers, and it significantly increased oxidative phosphorylation and ATP production in the present work, which is required for the survival of cancer cells. In contrast, BCS1L-S was unable to localize to the mitochondria as BCS1L-L did, and this led to impaired metabolic function. Mechanistically, splicing factor USP39 promoted exon 2 inclusion, thus facilitating the generation of oncogenic BCS1L-L and, thereby, maintaining mitochondrial homeostasis and survival of ovarian cancer cells. Importantly, we developed splice-switch antisense oligonucleotides (ASOs) that successfully induced exon 2 skipping and decreased BCS1L-L abundance, resulting in impaired tumor growth. These findings suggest that targeting oncogenic BCS1L-L by ASOs is a novel approach for ovarian cancer treatment.
- 3 March 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessSplice-switching of the oncogenic BCS1L isoform suppresses ovarian cancer progression by disrupting mitochondrial function
Increasing evidences demonstrate that mitochondrial function is essential for cancer cell survival and metastasis. However, the role of mitochondrial metabolic reprogramming in ovarian cancer progression remains largely unknown. Here, we report that mitochondrial chaperone BCS1L generates two major alternative-spliced isoforms, a full-length isoform ( BCS1L-L ) and a short isoform lacking exon 2 ( BCS1L-S ). Interestingly, BCS1L-L is elevated in several human cancers, and it significantly increased oxidative phosphorylation and ATP production in the present work, which is required for the survival of cancer cells. In contrast, BCS1L-S was unable to localize to the mitochondria as BCS1L-L did, and this led to impaired metabolic function. Mechanistically, splicing factor USP39 promoted exon 2 inclusion, thus facilitating the generation of oncogenic BCS1L-L and, thereby, maintaining mitochondrial homeostasis and survival of ovarian cancer cells. Importantly, we developed splice-switch antisense oligonucleotides (ASOs) that successfully induced exon 2 skipping and decreased BCS1L-L abundance, resulting in impaired tumor growth. These findings suggest that targeting oncogenic BCS1L-L by ASOs is a novel approach for ovarian cancer treatment.
- 1 October 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 83, 41-50
SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis
- 1 October 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 83, 41-50
SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis
- Open Access
- 30 April 2016
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 7 (1) , 1-13
The role of long-term label-retaining cells in the regeneration of adult mouse kidney after ischemia/reperfusion injury
Background: Label-retaining cells (LRCs) have been recognized as rare stem and progenitor-like cells, but their complex biological features in renal repair at the cellular level have never been reported. This study was conducted to evaluate whether LRCs in kidney are indeed renal stem/progenitor cells and to delineate their potential role in kidney regeneration. Methods: We utilized a long-term pulse chase of 5-bromo-2'-deoxyuridine (BrdU)-labeled cells in C57BL/6J mice to identify renal LRCs. We tracked the precise morphological characteristics and locations of BrdU+LRCs by both immunohistochemistry and immunofluorescence. To examine whether these BrdU+LRCs contribute to the repair of acute kidney injury, we analyzed biological characteristics of BrdU+LRCs in mice after ischemia/reperfusion (I/R) injury. Results: The findings revealed that the nuclei of BrdU+ LRCs exhibited different morphological characteristics in normal adult kidneys, including nuclei in pairs or scattered, fragmented or intact, strongly or weakly positive. Only 24.3 ± 1.5 % of BrdU+ LRCs co-expressed with Ki67 and 9.1 ± 1.4 % of BrdU+ LRCs were positive for TUNEL following renal I/R injury. Interestingly, we found that newly regenerated cells formed a niche-like structure and LRCs in pairs tended to locate in this structure, but the number of those LRCs was very low. We found a few scattered LRCs co-expressed Lotus tetragonolobus agglutinin (LTA) in the early phase of injury, suggesting differentiation of those LRCs in mouse kidney. Conclusions: Our findings suggest that LRCs are not a simple type of slow-cycling cells in adult kidneys, indicating a limited role of these cells in the regeneration of I/R injured kidney. Thus, LRCs cannot reliably be considered stem/progenitor cells in the regeneration of adult mouse kidney. When researchers use this technique to study the cellular basis of renal repair, these complex features of renal LRCs and the purity of real stem cells among renal LRCs should be considered.
- 30 April 2016
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 7 (1) , 1-13
Open AccessThe role of long-term label-retaining cells in the regeneration of adult mouse kidney after ischemia/reperfusion injury
Background: Label-retaining cells (LRCs) have been recognized as rare stem and progenitor-like cells, but their complex biological features in renal repair at the cellular level have never been reported. This study was conducted to evaluate whether LRCs in kidney are indeed renal stem/progenitor cells and to delineate their potential role in kidney regeneration. Methods: We utilized a long-term pulse chase of 5-bromo-2'-deoxyuridine (BrdU)-labeled cells in C57BL/6J mice to identify renal LRCs. We tracked the precise morphological characteristics and locations of BrdU+LRCs by both immunohistochemistry and immunofluorescence. To examine whether these BrdU+LRCs contribute to the repair of acute kidney injury, we analyzed biological characteristics of BrdU+LRCs in mice after ischemia/reperfusion (I/R) injury. Results: The findings revealed that the nuclei of BrdU+ LRCs exhibited different morphological characteristics in normal adult kidneys, including nuclei in pairs or scattered, fragmented or intact, strongly or weakly positive. Only 24.3 ± 1.5 % of BrdU+ LRCs co-expressed with Ki67 and 9.1 ± 1.4 % of BrdU+ LRCs were positive for TUNEL following renal I/R injury. Interestingly, we found that newly regenerated cells formed a niche-like structure and LRCs in pairs tended to locate in this structure, but the number of those LRCs was very low. We found a few scattered LRCs co-expressed Lotus tetragonolobus agglutinin (LTA) in the early phase of injury, suggesting differentiation of those LRCs in mouse kidney. Conclusions: Our findings suggest that LRCs are not a simple type of slow-cycling cells in adult kidneys, indicating a limited role of these cells in the regeneration of I/R injured kidney. Thus, LRCs cannot reliably be considered stem/progenitor cells in the regeneration of adult mouse kidney. When researchers use this technique to study the cellular basis of renal repair, these complex features of renal LRCs and the purity of real stem cells among renal LRCs should be considered.
- 1 February 2016
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 37 (5) , 645-655
Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciences
- 1 February 2016
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 37 (5) , 645-655
Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciences
- 1 November 2014
- Published by Elsevier in International Immunopharmacology
- Vol. 23 (1) , 236-246
Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation
- 1 November 2014
- Published by Elsevier in International Immunopharmacology
- Vol. 23 (1) , 236-246
Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation
- 1 October 2014
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 68 (8) , 1079-1088
Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1
- 1 October 2014
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 68 (8) , 1079-1088
Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1
- 1 October 2014
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 106 (1) , 101-109
TRB3, up-regulated in kidneys of rats with type1 diabetes, mediates extracellular matrix accumulation in vivo and in vitro
- 1 October 2014
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 106 (1) , 101-109
TRB3, up-regulated in kidneys of rats with type1 diabetes, mediates extracellular matrix accumulation in vivo and in vitro
- 13 June 2014
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 15 (2) , 167-177
TRB3 mediates renal tubular cell apoptosis associated with proteinuria
- 13 June 2014
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 15 (2) , 167-177
TRB3 mediates renal tubular cell apoptosis associated with proteinuria
- 1 April 2014
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 104 (1) , 143-154
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress
- 1 April 2014
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 104 (1) , 143-154
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress